Roseola epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(5 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{Roseola}}
{{Roseola}}


{{CMG}}; {{AE}}
{{CMG}}; {{AE}}{{DAMI}}


==Overview==
==Overview==
Roseola is an illness of young children, with a peak [[prevalence]] between 7 and 13 months. Ninety percent of cases occur in children younger than two years. Roseola occurs equally in boys and girls. It occurs throughout the year, although outbreaks may occur in groups according to season .
There is no accurate data for the [[prevalence]] or [[incidence]] of roseola. This is because the disease is a self limiting disease and it is under reported in most cases. Roseola is an illness of young children, with a peak [[prevalence]] between 7 and 13 months. Ninety percent of cases occur in children younger than two years. Roseola occurs equally in boys and girls. It occurs throughout the year, although outbreaks may occur in groups according to season .


==Epidemiology and demographics==
==Epidemiology and demographics==
Line 11: Line 11:
===Prevalence===
===Prevalence===
*There is no accurate data for the [[prevalence]] or [[incidence]] of roseola.  
*There is no accurate data for the [[prevalence]] or [[incidence]] of roseola.  
*More than 90% of adult populations in developed countries are [[seropositive]] for HHV6.
*More than 90% of adult populations in developed countries are [[seropositive]] for HHV 6.


===Age===
===Age===
Line 17: Line 17:


===Gender===
===Gender===
*Boys and girls are affected equally by roseola.<ref name="pmid8265302">{{cite journal| author=Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T et al.| title=Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). | journal=Pediatrics | year= 1994 | volume= 93 | issue= 1 | pages= 104-8 | pmid=8265302 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8265302  }} </ref>
*Males and females are affected equally by roseola.<ref name="pmid8265302">{{cite journal| author=Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T et al.| title=Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). | journal=Pediatrics | year= 1994 | volume= 93 | issue= 1 | pages= 104-8 | pmid=8265302 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8265302  }} </ref>


===Race===
===Race===
Line 27: Line 27:


===Developing countries===
===Developing countries===
*There is a strong association of HHV6A in Zambian children when compared to rest of the world.
*There is a strong association of HHV 6A in Zambian children when compared to rest of the world.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Neurology]]
[[Category:Pediatrics]]
[[Category:Dermatology]]

Latest revision as of 00:03, 30 July 2020

Roseola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Roseola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Roseola epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Roseola epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Roseola epidemiology and demographics

CDC on Roseola epidemiology and demographics

Roseola epidemiology and demographics in the news

Blogs on Roseola epidemiology and demographics

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Roseola epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

There is no accurate data for the prevalence or incidence of roseola. This is because the disease is a self limiting disease and it is under reported in most cases. Roseola is an illness of young children, with a peak prevalence between 7 and 13 months. Ninety percent of cases occur in children younger than two years. Roseola occurs equally in boys and girls. It occurs throughout the year, although outbreaks may occur in groups according to season .

Epidemiology and demographics

Prevalence

  • There is no accurate data for the prevalence or incidence of roseola.
  • More than 90% of adult populations in developed countries are seropositive for HHV 6.

Age

Roseola commonly affects young children between the ages of 7 and 13 months.[1]

Gender

  • Males and females are affected equally by roseola.[2]

Race

  • There is no racial predilection for roseola.

Developed countries

  • HHV6 infection is nearly universal accounting for 10-45% of febrile illness in infants.

Developing countries

  • There is a strong association of HHV 6A in Zambian children when compared to rest of the world.

References

  1. JURETIC M (1963). "Exanthema subitum a review of 243 cases". Helv Paediatr Acta. 18: 80–95. PMID 13958107.
  2. Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T; et al. (1994). "Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum)". Pediatrics. 93 (1): 104–8. PMID 8265302.